These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12076076)

  • 1. Somatostatin analogs inhibit neonatal retinal neovascularization.
    Higgins RD; Yan Y; Schrier BK
    Exp Eye Res; 2002 May; 74(5):553-9. PubMed ID: 12076076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice.
    Lange C; Ehlken C; Martin G; Konzok K; Moscoso Del Prado J; Hansen LL; Agostini HT
    Exp Eye Res; 2007 Sep; 85(3):323-7. PubMed ID: 17662276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
    Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalamine improves retinal neovascularization.
    Higgins RD; Sanders RJ; Yan Y; Zasloff M; Williams JI
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1507-12. PubMed ID: 10798670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.
    Wilkinson-Berka JL; Lofthouse S; Jaworski K; Ninkovic S; Tachas G; Wraight CJ
    Mol Vis; 2007 Aug; 13():1529-38. PubMed ID: 17893652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol is a potent inhibitor of retinal neovascularization.
    Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.
    Higgins RD; Yu K; Sanders RJ; Nandgaonkar BN; Rotschild T; Rifkin DB
    Curr Eye Res; 1999 Jan; 18(1):20-7. PubMed ID: 10075199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
    Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
    Stitt AW; Graham D; Gardiner TA
    Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.
    Leske DA; Wu J; Mookadam M; Chen Y; Fautsch MP; Holmes JM; Lanier WL
    Curr Eye Res; 2006 Feb; 31(2):163-9. PubMed ID: 16500767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile and regulation of telomerase reverse transcriptase on oxygen-induced retinal neovascularization.
    Min X; Zhou Q; Dong X; Wang Y; Xie L
    Curr Eye Res; 2011 Feb; 36(2):135-42. PubMed ID: 21158588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
    Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
    Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.